According to Portage Biotech's latest financial reports the company has $31.33 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-03-31 | $75.39 M | -54.43% |
2022-03-31 | $0.16 B | 12.08% |
2021-03-31 | $0.14 B | 1.35% |
2020-03-31 | $0.14 B | -1.96% |
2019-03-31 | $0.14 B | 1444.41% |
2018-03-31 | $9.61 M | -83.86% |
2017-03-31 | $59.59 M | 383.36% |
2016-03-31 | $12.32 M | 199.59% |
2015-03-31 | $4.11 M | -18.85% |
2014-03-31 | $5.07 M | 69.95% |
2013-03-31 | $2.98 M | -38.5% |
2012-03-31 | $4.85 M | -45.72% |
2011-03-31 | $8.93 M | 30.08% |
2010-03-31 | $6.87 M | 502.22% |
2009-03-31 | $1.14 M | -77.33% |
2008-03-31 | $5.03 M | -12.36% |
2007-03-31 | $5.74 M | 26.65% |
2006-03-31 | $4.53 M | 10.79% |
2005-03-31 | $4.09 M | 141.8% |
2004-03-31 | $1.69 M | -889.96% |
2003-03-31 | $-0.22 M | -7112.68% |
2002-03-31 | $0 M | -99.37% |
2001-03-31 | $0.48 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.88 M | -109.18% | Bahamas |
NRC Health
NRC | $36.94 M | 17.92% | ๐บ๐ธ USA |